The younger the child, the weaker the resistance, the immune system is not fully developed. Especially between the ages of 6 months and 3 years - the so-called "immune gap" period in children.

On February 6th, 2022 (the 6th day of the Lunar New Year), the company's Board of Management, along with the heads and deputy heads of departments and divisions, attended the meeting to open the year of the Tiger Spring 2022 online with the North Central, the Central and the South regions. The meeting took place in a joyful and excited atmosphere with the New Year's greetings from the CEO, followed by a report on the Tet holiday situation of employees in the regions.

On January 14th, 2022 at Vietnam National Convention Center, Hanoi City, Traphaco is honored for the second time in a row as the most prestigious oriental medicine company in Vietnam's pharmaceutical industry. The ceremony was organized by Vietnam Report Joint Stock Company (Vietnam Report) in collaboration with VietnamNet Newspaper - Ministry of Information and Communications.

On the afternoon of January 10th, the Party Committee of Hanoi Business Sector held a conference to review the work in 2021 and deploy tasks in 2022. At this conference, the Party Committee of Traphaco Joint Stock Company was honored to be one of 10 typical units of the Party Committee of the Bloc received the Certificate of Merit from the Hanoi Party Committee, the Party Committee was also awarded a certificate of merit by the Party Committee of the Hanoi Enterprise Division for the unit that met the standard of "Pure and strong typical".

On the evening of January 9th, the 15th program "Spring for children" took place at the Opera House (Hanoi), also marking the 15-years journey of Traphaco that accompany with the program and also disadvantaged children around the country.

On December 14th, 2021, Vietnam Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious pharmaceutical companies in 2021. Accordingly, Traphaco Joint Stock Company is honored to be in the Top 10 Prestigious Pharmaceutical Companies and 1st Top 5 Prestigious Oriental Pharmaceutical Companies in 2021.

On December 9th, 2021, Traphaco Joint Stock Company held the Commercialization Kick Off Ceremony for Technology Transfer Products from Daewoong and launched first product to the market, Ursodeoxycholic Acid (UDCA).

On November 18th, 2021, the Board of Directors of Traphaco Joint Stock Company organized a conference about the Company’s Restructuring Plan and the Announcement Ceremony of decisions on assigning and temporarily assigning tasks to key personnel at the Deputy CEO and the Functional Director level that are appointed by the Board of Directors.

On August 19th, 2021, Traphaco Joint Stock Company and Daewoong Pharmaceutical Limited Company, Korea (Daewoong) organized the kick off meeting of Technology Transfer Project for the the Phase 2.

Maintaining activities to cooperate with the community and society to prevent the Covid-19 epidemic, on May 14th, 2021 Traphaco Joint Stock Company and TML Volunteer group (Technic Medical Labs) continued to give 10 test chambers Mobile COVID-19 for 3 provinces: Bac Giang (5 chambers), Bac Ninh (3 chambers), Thai Binh (2 chambers). Previously, the group gave 05 chambers to Hanoi CDC.